238 related articles for article (PubMed ID: 34894252)
1. Interluekin-6 inhibitors for the treatment of adult-onset Still's disease.
Kaneko Y
Mod Rheumatol; 2022 Jan; 32(1):12-15. PubMed ID: 34894252
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-6 inhibition: a therapeutic strategy for the management of adult-onset Still's disease.
Kaneko Y; Takeuchi T
Expert Opin Biol Ther; 2022 Jan; 22(1):79-85. PubMed ID: 34126828
[TBL] [Abstract][Full Text] [Related]
3. Adult-onset Still's disease: can recent advances in our understanding of its pathogenesis lead to targeted therapy?
Efthimiou P; Kontzias A; Ward CM; Ogden NS
Nat Clin Pract Rheumatol; 2007 Jun; 3(6):328-35. PubMed ID: 17538564
[TBL] [Abstract][Full Text] [Related]
4. Severe delayed hypersensitivity reactions to IL-1 and IL-6 inhibitors link to common HLA-DRB1*15 alleles.
Saper VE; Ombrello MJ; Tremoulet AH; Montero-Martin G; Prahalad S; Canna S; Shimizu C; Deutsch G; Tan SY; Remmers EF; Monos D; Hahn T; Phadke OK; Cassidy E; Ferguson I; Mallajosyula V; Xu J; Rosa Duque JS; Chua GT; Ghosh D; Szymanski AM; Rubin D; Burns JC; Tian L; Fernandez-Vina MA; Mellins ED; Hollenbach JA; ;
Ann Rheum Dis; 2022 Mar; 81(3):406-415. PubMed ID: 34789453
[TBL] [Abstract][Full Text] [Related]
5. Adult-onset Still's disease.
Gerfaud-Valentin M; Jamilloux Y; Iwaz J; Sève P
Autoimmun Rev; 2014 Jul; 13(7):708-22. PubMed ID: 24657513
[TBL] [Abstract][Full Text] [Related]
6. Urticarial rash, fever, and arthritis: A case of refractory Adult-onset Still's disease with good response to tocilizumab.
Wawrzycki B; Krasowska D; Pietrzak A; Wielosz E; Majdan M; Lotti T
Dermatol Ther; 2019 Sep; 32(5):e13041. PubMed ID: 31361930
[TBL] [Abstract][Full Text] [Related]
7. Adult-Onset Still's Disease (AOSD): Advances in Understanding Pathophysiology, Genetics and Emerging Treatment Options.
Bindoli S; Baggio C; Doria A; Sfriso P
Drugs; 2024 Mar; 84(3):257-274. PubMed ID: 38441807
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-18 as a diagnostic marker of adult-onset Still's disease in older patients: a case report and review of the literature.
Usuda D; Furumura Y; Takeshima K; Sangen R; Kawai Y; Kasamaki Y; Iinuma Y; Kanda T
J Med Case Rep; 2018 Jul; 12(1):198. PubMed ID: 29986752
[TBL] [Abstract][Full Text] [Related]
9. Adult-onset Still's disease with disseminated intravascular coagulation and hemophagocytic syndrome: a case report.
Mimura T; Shimodaira M; Kibata M; Tsukadaira A; Shirahata K
BMC Res Notes; 2014 Dec; 7():940. PubMed ID: 25532568
[TBL] [Abstract][Full Text] [Related]
10. [Antagonists of interleukin-6 (tocilizumab), in adult refractory still disease].
Sekkach Y; Elqatni M; Khattabi AE; Fatihi J; Hammi S; Badaoui M; Elomri N; Mekouar F; Amezyane T; Abouzahir A; Ghafir D
Presse Med; 2011; 40(7-8):e333-7. PubMed ID: 21550202
[TBL] [Abstract][Full Text] [Related]
11. Pathogenesis and management of adult-onset Still's disease.
Efthimiou P; Georgy S
Semin Arthritis Rheum; 2006 Dec; 36(3):144-52. PubMed ID: 16949136
[TBL] [Abstract][Full Text] [Related]
12. Adult-onset Still's disease: Advances in the treatment.
Castañeda S; Blanco R; González-Gay MA
Best Pract Res Clin Rheumatol; 2016 Apr; 30(2):222-238. PubMed ID: 27886796
[TBL] [Abstract][Full Text] [Related]
13. [Adult-onset Still's disease revealed by a pericardial tamponade: report of two cases].
Ben Ghorbel I; Lamloum M; Miled M; Aoun N; Houman MH; Pouchot J
Rev Med Interne; 2006 Jul; 27(7):546-9. PubMed ID: 16678940
[TBL] [Abstract][Full Text] [Related]
14. Management of adult-onset Still's disease with interleukin-1 inhibitors: evidence- and consensus-based statements by a panel of Italian experts.
Colafrancesco S; Manara M; Bortoluzzi A; Serban T; Bianchi G; Cantarini L; Ciccia F; Dagna L; Govoni M; Montecucco C; Priori R; Ravelli A; Sfriso P; Sinigaglia L;
Arthritis Res Ther; 2019 Dec; 21(1):275. PubMed ID: 31829244
[TBL] [Abstract][Full Text] [Related]
15. Proinflammatory cytokine profiles in sera and pathological tissues of patients with active untreated adult onset Still's disease.
Chen DY; Lan JL; Lin FJ; Hsieh TY
J Rheumatol; 2004 Nov; 31(11):2189-98. PubMed ID: 15517632
[TBL] [Abstract][Full Text] [Related]
16. Adult-Onset Still's Disease-A Complex Disease, a Challenging Treatment.
Macovei LA; Burlui A; Bratoiu I; Rezus C; Cardoneanu A; Richter P; Szalontay A; Rezus E
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361602
[TBL] [Abstract][Full Text] [Related]
17. Biological treatment in adult-onset Still's disease.
Pouchot J; Arlet JB
Best Pract Res Clin Rheumatol; 2012 Aug; 26(4):477-87. PubMed ID: 23040362
[TBL] [Abstract][Full Text] [Related]
18. Autoinflammatory Pathogenesis and Targeted Therapy for Adult-Onset Still's Disease.
Li S; Zheng S; Tang S; Pan Y; Zhang S; Fang H; Qiao J
Clin Rev Allergy Immunol; 2020 Feb; 58(1):71-81. PubMed ID: 31147820
[TBL] [Abstract][Full Text] [Related]
19. Adult-onset Still's Disease: A Case Report.
Sapkota A; Pokhrel N; Adhikari J; Shrestha B; Yadav YK
JNMA J Nepal Med Assoc; 2020 Feb; 58(222):115-118. PubMed ID: 32335625
[TBL] [Abstract][Full Text] [Related]
20. [Adult-onset Still's disease : Rare adult-onset autoinflammatory syndrome].
Oms E; Tronnier M
Hautarzt; 2019 Jul; 70(7):530-534. PubMed ID: 30937478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]